| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |